Miraca Life Sciences’ expert pathology labs provide physicians with the information they need to make important individualized treatment decisions. We believe that better information can lead to more effective treatment selection and ultimately to better outcomes for patients with cancer and other complex diseases.
Our specialists have a proven track record of accurately diagnosing difficult cases — from distinguishing between similar conditions to accurately identifying the effects of medications and other factors.
Many of our pathologists are faculty members at leading institutions nationwide and actively participate in research initiatives. Through rigorous quality assurance, daily conferences, and close relationships with clinical partners, we continuously improve diagnostic precision for the thousands of patients we serve each day.
Miraca Life Sciences is a subsidiary of Miraca Holdings, Inc., Japan’s largest clinical pathology diagnostics and laboratory testing service provider. The company, previously known as Caris Diagnostics, was renamed Miraca Life Sciences in February 2012.